img

Global CD55 Antibody Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global CD55 Antibody Market Insights, Forecast to 2034

CD55 (decay-accelerating factor, DAF) is a GPI-anchored membrane glycoprotein that protects autologous cells from classical and alternative pathway of complement cascade.
Market Analysis and InsightsGlobal CD55 Antibody Market
Global CD55 Antibody market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, CD55 Antibody industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, CD55 Antibody key companies include Merck, Thermo Fisher Scientific, Proteintech Group, Aviva Systems Biology, LifeSpan BioSciences, RayBiotech, Leading Biology, ProSci and Bethyl Laboratories, etc. Merck, Thermo Fisher Scientific, Proteintech Group are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of CD55 Antibody were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole CD55 Antibody market and estimated to attract more attentions from industry insiders and investors.
CD55 Antibody can be divided into Monoclonal and Polyclonal, etc. Monoclonal is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
CD55 Antibody is widely used in various fields, such as Immunochemistry (IHC), Immunofluorescence (IF), Immunoprecipitation (IP) and Western Blot (WB), etc. Immunochemistry (IHC) provides greatest supports to the CD55 Antibody industry development. In 2022, global % revenue of CD55 Antibody went into Immunochemistry (IHC) filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global CD55 Antibody market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global CD55 Antibody market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Merck
Thermo Fisher Scientific
Proteintech Group
Aviva Systems Biology
LifeSpan BioSciences
RayBiotech
Leading Biology
ProSci
Bethyl Laboratories
OriGene Technologies
Novus Biologicals
Cell Signaling Technology
Abcam
GeneTex
United States Biological
St John's Laboratory
Creative Diagnostics
Biobyt
Jingjie PTM BioLab
Segment by Type
Monoclonal
Polyclonal

Segment by Application


Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, CD55 Antibody introduction, etc. CD55 Antibody Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of CD55 Antibody
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD55 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global CD55 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CD55 Antibody Market Perspective (2018-2033)
2.2 Global CD55 Antibody Growth Trends by Region
2.2.1 CD55 Antibody Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 CD55 Antibody Historic Market Size by Region (2018-2023)
2.2.3 CD55 Antibody Forecasted Market Size by Region (2024-2033)
2.3 CD55 Antibody Market Dynamics
2.3.1 CD55 Antibody Industry Trends
2.3.2 CD55 Antibody Market Drivers
2.3.3 CD55 Antibody Market Challenges
2.3.4 CD55 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue CD55 Antibody by Players
3.1.1 Global CD55 Antibody Revenue by Players (2018-2023)
3.1.2 Global CD55 Antibody Revenue Market Share by Players (2018-2023)
3.2 Global CD55 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of CD55 Antibody, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global CD55 Antibody Market Concentration Ratio
3.4.1 Global CD55 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD55 Antibody Revenue in 2022
3.5 Global Key Players of CD55 Antibody Head office and Area Served
3.6 Global Key Players of CD55 Antibody, Product and Application
3.7 Global Key Players of CD55 Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CD55 Antibody Breakdown Data by Type
4.1 Global CD55 Antibody Historic Market Size by Type (2018-2023)
4.2 Global CD55 Antibody Forecasted Market Size by Type (2024-2033)
5 CD55 Antibody Breakdown Data by Application
5.1 Global CD55 Antibody Historic Market Size by Application (2018-2023)
5.2 Global CD55 Antibody Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America CD55 Antibody Market Size (2018-2033)
6.2 North America CD55 Antibody Market Size by Type
6.2.1 North America CD55 Antibody Market Size by Type (2018-2023)
6.2.2 North America CD55 Antibody Market Size by Type (2024-2033)
6.2.3 North America CD55 Antibody Market Share by Type (2018-2033)
6.3 North America CD55 Antibody Market Size by Application
6.3.1 North America CD55 Antibody Market Size by Application (2018-2023)
6.3.2 North America CD55 Antibody Market Size by Application (2024-2033)
6.3.3 North America CD55 Antibody Market Share by Application (2018-2033)
6.4 North America CD55 Antibody Market Size by Country
6.4.1 North America CD55 Antibody Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America CD55 Antibody Market Size by Country (2018-2023)
6.4.3 North America CD55 Antibody Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe CD55 Antibody Market Size (2018-2033)
7.2 Europe CD55 Antibody Market Size by Type
7.2.1 Europe CD55 Antibody Market Size by Type (2018-2023)
7.2.2 Europe CD55 Antibody Market Size by Type (2024-2033)
7.2.3 Europe CD55 Antibody Market Share by Type (2018-2033)
7.3 Europe CD55 Antibody Market Size by Application
7.3.1 Europe CD55 Antibody Market Size by Application (2018-2023)
7.3.2 Europe CD55 Antibody Market Size by Application (2024-2033)
7.3.3 Europe CD55 Antibody Market Share by Application (2018-2033)
7.4 Europe CD55 Antibody Market Size by Country
7.4.1 Europe CD55 Antibody Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe CD55 Antibody Market Size by Country (2018-2023)
7.4.3 Europe CD55 Antibody Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China CD55 Antibody Market Size (2018-2033)
8.2 China CD55 Antibody Market Size by Type
8.2.1 China CD55 Antibody Market Size by Type (2018-2023)
8.2.2 China CD55 Antibody Market Size by Type (2024-2033)
8.2.3 China CD55 Antibody Market Share by Type (2018-2033)
8.3 China CD55 Antibody Market Size by Application
8.3.1 China CD55 Antibody Market Size by Application (2018-2023)
8.3.2 China CD55 Antibody Market Size by Application (2024-2033)
8.3.3 China CD55 Antibody Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia CD55 Antibody Market Size (2018-2033)
9.2 Asia CD55 Antibody Market Size by Type
9.2.1 Asia CD55 Antibody Market Size by Type (2018-2023)
9.2.2 Asia CD55 Antibody Market Size by Type (2024-2033)
9.2.3 Asia CD55 Antibody Market Share by Type (2018-2033)
9.3 Asia CD55 Antibody Market Size by Application
9.3.1 Asia CD55 Antibody Market Size by Application (2018-2023)
9.3.2 Asia CD55 Antibody Market Size by Application (2024-2033)
9.3.3 Asia CD55 Antibody Market Share by Application (2018-2033)
9.4 Asia CD55 Antibody Market Size by Region
9.4.1 Asia CD55 Antibody Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia CD55 Antibody Market Size by Region (2018-2023)
9.4.3 Asia CD55 Antibody Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America CD55 Antibody Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America CD55 Antibody Market Size by Type
10.2.1 Middle East, Africa, and Latin America CD55 Antibody Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America CD55 Antibody Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America CD55 Antibody Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America CD55 Antibody Market Size by Application
10.3.1 Middle East, Africa, and Latin America CD55 Antibody Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America CD55 Antibody Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America CD55 Antibody Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America CD55 Antibody Market Size by Country
10.4.1 Middle East, Africa, and Latin America CD55 Antibody Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America CD55 Antibody Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America CD55 Antibody Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck CD55 Antibody Introduction
11.1.4 Merck Revenue in CD55 Antibody Business (2018-2023)
11.1.5 Merck Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific CD55 Antibody Introduction
11.2.4 Thermo Fisher Scientific Revenue in CD55 Antibody Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Proteintech Group
11.3.1 Proteintech Group Company Details
11.3.2 Proteintech Group Business Overview
11.3.3 Proteintech Group CD55 Antibody Introduction
11.3.4 Proteintech Group Revenue in CD55 Antibody Business (2018-2023)
11.3.5 Proteintech Group Recent Developments
11.4 Aviva Systems Biology
11.4.1 Aviva Systems Biology Company Details
11.4.2 Aviva Systems Biology Business Overview
11.4.3 Aviva Systems Biology CD55 Antibody Introduction
11.4.4 Aviva Systems Biology Revenue in CD55 Antibody Business (2018-2023)
11.4.5 Aviva Systems Biology Recent Developments
11.5 LifeSpan BioSciences
11.5.1 LifeSpan BioSciences Company Details
11.5.2 LifeSpan BioSciences Business Overview
11.5.3 LifeSpan BioSciences CD55 Antibody Introduction
11.5.4 LifeSpan BioSciences Revenue in CD55 Antibody Business (2018-2023)
11.5.5 LifeSpan BioSciences Recent Developments
11.6 RayBiotech
11.6.1 RayBiotech Company Details
11.6.2 RayBiotech Business Overview
11.6.3 RayBiotech CD55 Antibody Introduction
11.6.4 RayBiotech Revenue in CD55 Antibody Business (2018-2023)
11.6.5 RayBiotech Recent Developments
11.7 Leading Biology
11.7.1 Leading Biology Company Details
11.7.2 Leading Biology Business Overview
11.7.3 Leading Biology CD55 Antibody Introduction
11.7.4 Leading Biology Revenue in CD55 Antibody Business (2018-2023)
11.7.5 Leading Biology Recent Developments
11.8 ProSci
11.8.1 ProSci Company Details
11.8.2 ProSci Business Overview
11.8.3 ProSci CD55 Antibody Introduction
11.8.4 ProSci Revenue in CD55 Antibody Business (2018-2023)
11.8.5 ProSci Recent Developments
11.9 Bethyl Laboratories
11.9.1 Bethyl Laboratories Company Details
11.9.2 Bethyl Laboratories Business Overview
11.9.3 Bethyl Laboratories CD55 Antibody Introduction
11.9.4 Bethyl Laboratories Revenue in CD55 Antibody Business (2018-2023)
11.9.5 Bethyl Laboratories Recent Developments
11.10 OriGene Technologies
11.10.1 OriGene Technologies Company Details
11.10.2 OriGene Technologies Business Overview
11.10.3 OriGene Technologies CD55 Antibody Introduction
11.10.4 OriGene Technologies Revenue in CD55 Antibody Business (2018-2023)
11.10.5 OriGene Technologies Recent Developments
11.11 Novus Biologicals
11.11.1 Novus Biologicals Company Details
11.11.2 Novus Biologicals Business Overview
11.11.3 Novus Biologicals CD55 Antibody Introduction
11.11.4 Novus Biologicals Revenue in CD55 Antibody Business (2018-2023)
11.11.5 Novus Biologicals Recent Developments
11.12 Cell Signaling Technology
11.12.1 Cell Signaling Technology Company Details
11.12.2 Cell Signaling Technology Business Overview
11.12.3 Cell Signaling Technology CD55 Antibody Introduction
11.12.4 Cell Signaling Technology Revenue in CD55 Antibody Business (2018-2023)
11.12.5 Cell Signaling Technology Recent Developments
11.13 Abcam
11.13.1 Abcam Company Details
11.13.2 Abcam Business Overview
11.13.3 Abcam CD55 Antibody Introduction
11.13.4 Abcam Revenue in CD55 Antibody Business (2018-2023)
11.13.5 Abcam Recent Developments
11.14 GeneTex
11.14.1 GeneTex Company Details
11.14.2 GeneTex Business Overview
11.14.3 GeneTex CD55 Antibody Introduction
11.14.4 GeneTex Revenue in CD55 Antibody Business (2018-2023)
11.14.5 GeneTex Recent Developments
11.15 United States Biological
11.15.1 United States Biological Company Details
11.15.2 United States Biological Business Overview
11.15.3 United States Biological CD55 Antibody Introduction
11.15.4 United States Biological Revenue in CD55 Antibody Business (2018-2023)
11.15.5 United States Biological Recent Developments
11.16 St John's Laboratory
11.16.1 St John's Laboratory Company Details
11.16.2 St John's Laboratory Business Overview
11.16.3 St John's Laboratory CD55 Antibody Introduction
11.16.4 St John's Laboratory Revenue in CD55 Antibody Business (2018-2023)
11.16.5 St John's Laboratory Recent Developments
11.17 Creative Diagnostics
11.17.1 Creative Diagnostics Company Details
11.17.2 Creative Diagnostics Business Overview
11.17.3 Creative Diagnostics CD55 Antibody Introduction
11.17.4 Creative Diagnostics Revenue in CD55 Antibody Business (2018-2023)
11.17.5 Creative Diagnostics Recent Developments
11.18 Biobyt
11.18.1 Biobyt Company Details
11.18.2 Biobyt Business Overview
11.18.3 Biobyt CD55 Antibody Introduction
11.18.4 Biobyt Revenue in CD55 Antibody Business (2018-2023)
11.18.5 Biobyt Recent Developments
11.19 Jingjie PTM BioLab
11.19.1 Jingjie PTM BioLab Company Details
11.19.2 Jingjie PTM BioLab Business Overview
11.19.3 Jingjie PTM BioLab CD55 Antibody Introduction
11.19.4 Jingjie PTM BioLab Revenue in CD55 Antibody Business (2018-2023)
11.19.5 Jingjie PTM BioLab Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CD55 Antibody Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Monoclonal
Table 3. Key Players of Polyclonal
Table 4. Global CD55 Antibody Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global CD55 Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global CD55 Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global CD55 Antibody Market Share by Region (2018-2023)
Table 8. Global CD55 Antibody Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global CD55 Antibody Market Share by Region (2024-2033)
Table 10. CD55 Antibody Market Trends
Table 11. CD55 Antibody Market Drivers
Table 12. CD55 Antibody Market Challenges
Table 13. CD55 Antibody Market Restraints
Table 14. Global CD55 Antibody Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global CD55 Antibody Revenue Share by Players (2018-2023)
Table 16. Global Top CD55 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD55 Antibody as of 2022)
Table 17. Global CD55 Antibody Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by CD55 Antibody Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of CD55 Antibody, Headquarters and Area Served
Table 20. Global Key Players of CD55 Antibody, Product and Application
Table 21. Global Key Players of CD55 Antibody, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CD55 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global CD55 Antibody Revenue Market Share by Type (2018-2023)
Table 25. Global CD55 Antibody Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global CD55 Antibody Revenue Market Share by Type (2024-2033)
Table 27. Global CD55 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global CD55 Antibody Revenue Share by Application (2018-2023)
Table 29. Global CD55 Antibody Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global CD55 Antibody Revenue Share by Application (2024-2033)
Table 31. North America CD55 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America CD55 Antibody Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America CD55 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America CD55 Antibody Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America CD55 Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America CD55 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America CD55 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe CD55 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe CD55 Antibody Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe CD55 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe CD55 Antibody Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe CD55 Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe CD55 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe CD55 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 45. China CD55 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 46. China CD55 Antibody Market Size by Type (2024-2033) & (US$ Million)
Table 47. China CD55 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 48. China CD55 Antibody Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia CD55 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia CD55 Antibody Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia CD55 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia CD55 Antibody Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia CD55 Antibody Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia CD55 Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia CD55 Antibody Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America CD55 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America CD55 Antibody Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America CD55 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America CD55 Antibody Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America CD55 Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America CD55 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America CD55 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 63. Merck Company Details
Table 64. Merck Business Overview
Table 65. Merck CD55 Antibody Product
Table 66. Merck Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 67. Merck Recent Developments
Table 68. Thermo Fisher Scientific Company Details
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific CD55 Antibody Product
Table 71. Thermo Fisher Scientific Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Developments
Table 73. Proteintech Group Company Details
Table 74. Proteintech Group Business Overview
Table 75. Proteintech Group CD55 Antibody Product
Table 76. Proteintech Group Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 77. Proteintech Group Recent Developments
Table 78. Aviva Systems Biology Company Details
Table 79. Aviva Systems Biology Business Overview
Table 80. Aviva Systems Biology CD55 Antibody Product
Table 81. Aviva Systems Biology Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 82. Aviva Systems Biology Recent Developments
Table 83. LifeSpan BioSciences Company Details
Table 84. LifeSpan BioSciences Business Overview
Table 85. LifeSpan BioSciences CD55 Antibody Product
Table 86. LifeSpan BioSciences Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 87. LifeSpan BioSciences Recent Developments
Table 88. RayBiotech Company Details
Table 89. RayBiotech Business Overview
Table 90. RayBiotech CD55 Antibody Product
Table 91. RayBiotech Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 92. RayBiotech Recent Developments
Table 93. Leading Biology Company Details
Table 94. Leading Biology Business Overview
Table 95. Leading Biology CD55 Antibody Product
Table 96. Leading Biology Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 97. Leading Biology Recent Developments
Table 98. ProSci Company Details
Table 99. ProSci Business Overview
Table 100. ProSci CD55 Antibody Product
Table 101. ProSci Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 102. ProSci Recent Developments
Table 103. Bethyl Laboratories Company Details
Table 104. Bethyl Laboratories Business Overview
Table 105. Bethyl Laboratories CD55 Antibody Product
Table 106. Bethyl Laboratories Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 107. Bethyl Laboratories Recent Developments
Table 108. OriGene Technologies Company Details
Table 109. OriGene Technologies Business Overview
Table 110. OriGene Technologies CD55 Antibody Product
Table 111. OriGene Technologies Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 112. OriGene Technologies Recent Developments
Table 113. Novus Biologicals Company Details
Table 114. Novus Biologicals Business Overview
Table 115. Novus Biologicals CD55 Antibody Product
Table 116. Novus Biologicals Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 117. Novus Biologicals Recent Developments
Table 118. Cell Signaling Technology Company Details
Table 119. Cell Signaling Technology Business Overview
Table 120. Cell Signaling Technology CD55 Antibody Product
Table 121. Cell Signaling Technology Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 122. Cell Signaling Technology Recent Developments
Table 123. Abcam Company Details
Table 124. Abcam Business Overview
Table 125. Abcam CD55 Antibody Product
Table 126. Abcam Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 127. Abcam Recent Developments
Table 128. GeneTex Company Details
Table 129. GeneTex Business Overview
Table 130. GeneTex CD55 Antibody Product
Table 131. GeneTex Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 132. GeneTex Recent Developments
Table 133. United States Biological Company Details
Table 134. United States Biological Business Overview
Table 135. United States Biological CD55 Antibody Product
Table 136. United States Biological Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 137. United States Biological Recent Developments
Table 138. St John's Laboratory Company Details
Table 139. St John's Laboratory Business Overview
Table 140. St John's Laboratory CD55 Antibody Product
Table 141. St John's Laboratory Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 142. St John's Laboratory Recent Developments
Table 143. Creative Diagnostics Company Details
Table 144. Creative Diagnostics Business Overview
Table 145. Creative Diagnostics CD55 Antibody Product
Table 146. Creative Diagnostics Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 147. Creative Diagnostics Recent Developments
Table 148. Biobyt Company Details
Table 149. Biobyt Business Overview
Table 150. Biobyt CD55 Antibody Product
Table 151. Biobyt Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 152. Biobyt Recent Developments
Table 153. Jingjie PTM BioLab Company Details
Table 154. Jingjie PTM BioLab Business Overview
Table 155. Jingjie PTM BioLab CD55 Antibody Product
Table 156. Jingjie PTM BioLab Revenue in CD55 Antibody Business (2018-2023) & (US$ Million)
Table 157. Jingjie PTM BioLab Recent Developments
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CD55 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global CD55 Antibody Market Share by Type: 2022 VS 2033
Figure 3. Monoclonal Features
Figure 4. Polyclonal Features
Figure 5. Global CD55 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global CD55 Antibody Market Share by Application: 2022 VS 2033
Figure 7. Immunochemistry (IHC) Case Studies
Figure 8. Immunofluorescence (IF) Case Studies
Figure 9. Immunoprecipitation (IP) Case Studies
Figure 10. Western Blot (WB) Case Studies
Figure 11. ELISA Case Studies
Figure 12. Others Case Studies
Figure 13. CD55 Antibody Report Years Considered
Figure 14. Global CD55 Antibody Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global CD55 Antibody Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global CD55 Antibody Market Share by Region: 2022 VS 2033
Figure 17. Global CD55 Antibody Market Share by Players in 2022
Figure 18. Global Top CD55 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD55 Antibody as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by CD55 Antibody Revenue in 2022
Figure 20. North America CD55 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America CD55 Antibody Market Share by Type (2018-2033)
Figure 22. North America CD55 Antibody Market Share by Application (2018-2033)
Figure 23. North America CD55 Antibody Market Share by Country (2018-2033)
Figure 24. United States CD55 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada CD55 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe CD55 Antibody Market Size YoY (2018-2033) & (US$ Million)
Figure 27. Europe CD55 Antibody Market Share by Type (2018-2033)
Figure 28. Europe CD55 Antibody Market Share by Application (2018-2033)
Figure 29. Europe CD55 Antibody Market Share by Country (2018-2033)
Figure 30. Germany CD55 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France CD55 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. CD55 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy CD55 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia CD55 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries CD55 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. China CD55 Antibody Market Size YoY (2018-2033) & (US$ Million)
Figure 37. China CD55 Antibody Market Share by Type (2018-2033)
Figure 38. China CD55 Antibody Market Share by Application (2018-2033)
Figure 39. Asia CD55 Antibody Market Size YoY (2018-2033) & (US$ Million)
Figure 40. Asia CD55 Antibody Market Share by Type (2018-2033)
Figure 41. Asia CD55 Antibody Market Share by Application (2018-2033)
Figure 42. Asia CD55 Antibody Market Share by Region (2018-2033)
Figure 43. Japan CD55 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. South Korea CD55 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. China Taiwan CD55 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Southeast Asia CD55 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. India CD55 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Australia CD55 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America CD55 Antibody Market Size YoY (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America CD55 Antibody Market Share by Type (2018-2033)
Figure 51. Middle East, Africa, and Latin America CD55 Antibody Market Share by Application (2018-2033)
Figure 52. Middle East, Africa, and Latin America CD55 Antibody Market Share by Country (2018-2033)
Figure 53. Brazil CD55 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Mexico CD55 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Turkey CD55 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia CD55 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Israel CD55 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. GCC Countries CD55 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Merck Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 61. Proteintech Group Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 62. Aviva Systems Biology Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 63. LifeSpan BioSciences Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 64. RayBiotech Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 65. Leading Biology Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 66. ProSci Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 67. Bethyl Laboratories Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 68. OriGene Technologies Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 69. Novus Biologicals Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 70. Cell Signaling Technology Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 71. Abcam Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 72. GeneTex Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 73. United States Biological Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 74. St John's Laboratory Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 75. Creative Diagnostics Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 76. Biobyt Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 77. Jingjie PTM BioLab Revenue Growth Rate in CD55 Antibody Business (2018-2023)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries